In Potential Breakthrough, Dutch Study Shows How Use Of a “DNA Medication Pass” Can Significantly Reduce Adverse Events

Forbes February 3, 2023
Joshua Cohen

Since the unveiling of the human genome more than two decades ago, precision medicine has advanced to the point where it’s now integral to clinical drug development.

Equally important is the use of genetic information to diagnose disease and tailor treatment. Dutch researchers at the Leiden University Medical Center are doing just that. In a study published this week in The Lancet they point to a possible breakthrough in precision medicine. They used a so-called DNA medication pass to custom fit treatments across a wide range of disease areas. Adjusting the dosage of medications based on patients’ DNA profiles led to 30% fewer serious side effects.

In many areas of medicine, a one-size-fits all approach for prescribing medicines is becoming...

Today's Sponsors

Today's Sponsor